Catalyst Wire Dossier Catalyst Wire Dossier

DOTAREM

Gadoterate meglumine · Guerbet LLC
Drug timelines are a Plus or Pro feature.

37 regulatory and trial events tracked for DOTAREM, covering 2008-11-26 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance [NA]

See pricing